BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10930994)

  • 21. In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors.
    Viola JJ; Agbaria R; Walbridge S; Oshiro EM; Johns DG; Kelley JA; Oldfield EH; Ram Z
    Cancer Res; 1995 Mar; 55(6):1306-9. PubMed ID: 7882327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In situ regulation of mammalian CTP synthetase by allosteric inhibition.
    Aronow B; Ullman B
    J Biol Chem; 1987 Apr; 262(11):5106-12. PubMed ID: 2435724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a novel dUTP-dependent activity of CTP synthetase from Saccharomyces cerevisiae.
    Pappas A; Park TS; Carman GM
    Biochemistry; 1999 Dec; 38(50):16671-7. PubMed ID: 10600130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of CTP synthetase activity in crude cell homogenates by a fast and sensitive non-radiochemical assay using anion-exchange high-performance liquid chromatography.
    Van Kuilenburg AB; Elzinga L; Verschuur AC; Van den Berg AA; Slingerland RJ; Van Gennip AH
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 693(2):287-95. PubMed ID: 9210431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Ser424 as the protein kinase A phosphorylation site in CTP synthetase from Saccharomyces cerevisiae.
    Park TS; Ostrander DB; Pappas A; Carman GM
    Biochemistry; 1999 Jul; 38(27):8839-48. PubMed ID: 10393561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytidine triphosphate synthase activity and mRNA expression in normal human blood cells.
    Verschuur AC; Van Gennip AH; Muller EJ; Voûte PA; Vreken P; Van Kuilenburg AB
    Biol Chem; 1999 Jan; 380(1):41-6. PubMed ID: 10064135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited antitumor-effect associated with toxicity of the experimental cytotoxic drug cyclopentenyl cytosine in NOD/scid mice with acute lymphoblastic leukemia.
    Schimmel KJ; Nijmeijer BA; van Schie ML; Falkenburg JH; Guchelaar HJ
    Leuk Res; 2007 Nov; 31(11):1545-51. PubMed ID: 17459472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered cytidine triphosphate synthetase with reduced product inhibition.
    Zhu M; Sun W; Wang Y; Meng J; Zhang D; Guo T; Ouyang P; Ying H; Xie J
    Protein Eng Des Sel; 2014 Jul; 27(7):225-33. PubMed ID: 24902851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the Potent Inhibition of CTP Synthase by Gemcitabine-5'-Triphosphate.
    McCluskey GD; Mohamady S; Taylor SD; Bearne SL
    Chembiochem; 2016 Dec; 17(23):2240-2249. PubMed ID: 27643605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism.
    Heinemann V; Schulz L; Issels RD; Plunkett W
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):11-8. PubMed ID: 7481839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on neuroblastoma cell lines.
    Bierau J; van Gennip AH; Helleman J; van Kuilenburg AB
    Biochem Pharmacol; 2001 Oct; 62(8):1099-105. PubMed ID: 11597578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.
    Huang M; Whang P; Lewicki P; Mitchell BS
    Mol Pharmacol; 2011 Jul; 80(1):40-8. PubMed ID: 21464199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclopentenyl cytosine and neuroblastoma SK-N-BE(2)-C cell line cells.
    Slingerland RJ; Van Gennip AH; Bodlaender JM; Voûte PA; Van Kuilenburg AB
    Eur J Cancer; 1995; 31A(4):627-31. PubMed ID: 7576983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comments on: cylopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy. A.C. Verschuur et al. Eur J Cancer 2000, 36, 627-635.
    Parry TE
    Eur J Cancer; 2001 Jan; 37(2):290. PubMed ID: 11243234
    [No Abstract]   [Full Text] [Related]  

  • 35. The pyrimidin analogue cyclopentenyl cytosine induces alloantigen-specific non-responsiveness of human T lymphocytes.
    Nikolaeva N; Bemelman FJ; Yong SL; Verschuur A; van Lier RA; ten Berge IJ
    Clin Exp Immunol; 2008 Feb; 151(2):348-58. PubMed ID: 18062797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models.
    Van Bree C; Barten-Van Rijbroek AD; Leen R; Rodermond HM; Van Kuilenburg AB; Kal HB
    Int J Oncol; 2009 Mar; 34(3):813-9. PubMed ID: 19212686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia trachomatis CTP synthetase: molecular characterization and developmental regulation of expression.
    Wylie JL; Berry JD; McClarty G
    Mol Microbiol; 1996 Nov; 22(4):631-42. PubMed ID: 8951811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of cytidine triphosphate synthetase in Salmonella typhimurium by pyrimidines during uridine nucleotide depletion.
    West TP; O'Donovan GA
    J Gen Microbiol; 1982 Apr; 128(4):895-9. PubMed ID: 6750041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of uridine-cytidine kinase and CTP synthetase in the synthesis of CTP in malignant human T-lymphocytic cells.
    van den Berg AA; van Lenthe H; van Kuilenburg AB; van Gennip AH
    Adv Exp Med Biol; 1994; 370():261-4. PubMed ID: 7660903
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclopentenyl cytosine increases the phosphorylation and incorporation into dna of arabinofu-ranosyl cytosine in a myeloid leukemic cell-line.
    Verschuur AC; van Gennip AH; Leen R; Voûte PA; van Kuilenburg AB
    Adv Exp Med Biol; 2000; 486():311-7. PubMed ID: 11783507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.